Sasol Operating Income Over Time
| SAO Stock | EUR 7.30 0.15 2.01% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Sasol Performance and Sasol Correlation. Sasol |
Cross Equities Operating Income Analysis
Compare Sasol and related stocks such as Abbott Laboratories, DANAHER (DAPSG), and Merck Operating Income Over Time
| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ABL | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 3.2 B | 1.7 B | 3.6 B | 4.5 B | 5.4 B | 8.4 B | 8.4 B | 6.5 B | 6.8 B | 7.8 B | 5.9 B |
| DAP | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 2.8 B | 3 B | 3.4 B | 3.3 B | 4.2 B | 6.4 B | 7.5 B | 5.2 B | 4.9 B | 5.6 B | 5 B |
| 6MK | 6 B | 6 B | 6 B | 6 B | 6 B | 6 B | 6 B | 7.3 B | 8.9 B | 12.2 B | 5.5 B | 13.2 B | 18.3 B | 3 B | 20.2 B | 23.3 B | 24.4 B |
| AMD | (382 M) | (382 M) | (382 M) | (382 M) | (382 M) | (382 M) | (382 M) | 204 M | 451 M | 631 M | 1.4 B | 3.6 B | 1.3 B | 401 M | 2.1 B | 3.7 B | 3.9 B |
| 4I1 | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 10.8 B | 11.5 B | 11.3 B | 10.4 B | 11.6 B | 13 B | 12.2 B | 12.2 B | 13.4 B | 14.9 B | 13.4 B |
| W8V | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 220 B | 198 B | 176 B |
| TOTB | 4.6 B | 4.6 B | 4.6 B | 4.6 B | 4.6 B | 4.6 B | 4.6 B | 7 B | 15.3 B | 15.4 B | (7.3 B) | 23.9 B | 49.7 B | 30.9 B | 24.1 B | 27.7 B | 20 B |
| AMG | 9.8 B | 9.8 B | 9.8 B | 9.8 B | 9.8 B | 9.8 B | 9.8 B | 10 B | 10.3 B | 9.7 B | 9.1 B | 7.6 B | 9.6 B | 7.9 B | 7.3 B | 9.1 B | 7.2 B |
| HBC1 | 21.1 B | 21.1 B | 21.1 B | 21.1 B | 17 B | 17.2 B | 8.8 B | 15.4 B | 15.4 B | 15.4 B | 15.4 B | 15.4 B | 15.4 B | 15.4 B | 15.4 B | 13.9 B | 12.7 B |
| HK2C | 6.3 B | 6.3 B | 6.3 B | 6.3 B | 6.3 B | 6.3 B | 6.3 B | 7.2 B | 9.5 B | 8.5 B | 11.2 B | 13.6 B | 10.4 B | 8.5 B | 10 B | 11.6 B | 10.4 B |
Sasol and related stocks such as Abbott Laboratories, DANAHER (DAPSG), and Merck Operating Income description
Operating Income is the amount of profit realized from Sasol operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Sasol is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Sasol | SAO |
Specialization | Basic Materials, Specialty Chemicals |
| Business Address | Sasol Place, Johannesburg, |
| Exchange | Frankfurt Exchange |
EUR 7.3
Check out Sasol Performance and Sasol Correlation. For more detail on how to invest in Sasol Stock please use our How to Invest in Sasol guide.You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Sasol technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.